238.58MMarket Cap-5741P/E (TTM)
5.730High5.190Low864.48KVolume5.730Open5.750Pre Close4.63MTurnover2.09%Turnover RatioLossP/E (Static)44.68MShares6.42052wk High3.42P/B220.50MFloat Cap0.94052wk Low--Dividend TTM41.29MShs Float81.480Historical High--Div YieldTTM9.39%Amplitude0.450Historical Low5.357Avg Price1Lot Size
Cardiff Oncology Stock Forum
I got lucky on picking these, I think I'll keep these for the long. goodbye, I'm forgetting about this and starting another one in robinhood.
Oncology Stock Spikes 24% Amidst Investment Firm's New Price Target
In a significant development that has caught the attention of investors, Cardiff Oncology Inc. (NASDAQ: CRDF) saw an impressive 24% surge in their stock price yesterday, closing at $3.58. This sudden upswing comes amidst positive sentiments from leading investment banking and institutional securities firm, Piper Sandler, which has set a bullish price target of ...
🤘🏻
Market Summary 1st March 2024
Clinical-stage Oncology Company Beats Q4 Earnings & Revenue Estimates
Cardiff Oncology (NASDAQ: $CRDF), a clinical-stage biotechnology company, has just reported its fourth quarter results. The company beat analyst consensus estimates on both earnings and revenue, marking a significant milestone in its financial performance. $Cardiff Oncology(CRDF.US)$
https://stockregion.app/p/clinical-stage-oncology-company-beats
No comment yet